Bionano Genomics Statistics
Total Valuation
BNGO has a market cap or net worth of $17.42 million. The enterprise value is $20.57 million.
Important Dates
The next confirmed earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BNGO has 9.68 million shares outstanding. The number of shares has increased by 183.33% in one year.
| Current Share Class | 9.68M |
| Shares Outstanding | 9.68M |
| Shares Change (YoY) | +183.33% |
| Shares Change (QoQ) | +27.73% |
| Owned by Insiders (%) | 1.66% |
| Owned by Institutions (%) | 9.59% |
| Float | 8.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| Forward PS | 0.54 |
| PB Ratio | 0.16 |
| P/TBV Ratio | 0.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.43.
| Current Ratio | 1.76 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -91.34 |
Financial Efficiency
Return on equity (ROE) is -118.25% and return on invested capital (ROIC) is -36.66%.
| Return on Equity (ROE) | -118.25% |
| Return on Assets (ROA) | -30.86% |
| Return on Invested Capital (ROIC) | -36.66% |
| Return on Capital Employed (ROCE) | -97.81% |
| Revenue Per Employee | $274,260 |
| Profits Per Employee | -$743,290 |
| Employee Count | 100 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 1.85 |
Taxes
In the past 12 months, BNGO has paid $42,000 in taxes.
| Income Tax | 42,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.15% in the last 52 weeks. The beta is 2.34, so BNGO's price volatility has been higher than the market average.
| Beta (5Y) | 2.34 |
| 52-Week Price Change | -91.15% |
| 50-Day Moving Average | 2.54 |
| 200-Day Moving Average | 3.70 |
| Relative Strength Index (RSI) | 37.83 |
| Average Volume (20 Days) | 452,559 |
Short Selling Information
The latest short interest is 1.04 million, so 10.76% of the outstanding shares have been sold short.
| Short Interest | 1.04M |
| Short Previous Month | 1.37M |
| Short % of Shares Out | 10.76% |
| Short % of Float | 12.29% |
| Short Ratio (days to cover) | 0.73 |
Income Statement
In the last 12 months, BNGO had revenue of $27.43 million and -$74.33 million in losses. Loss per share was -$32.25.
| Revenue | 27.43M |
| Gross Profit | 1.39M |
| Operating Income | -50.70M |
| Pretax Income | -74.29M |
| Net Income | -74.33M |
| EBITDA | -37.86M |
| EBIT | -50.70M |
| Loss Per Share | -$32.25 |
Full Income StatementBalance Sheet
The company has $16.44 million in cash and $19.58 million in debt, giving a net cash position of -$3.14 million or -$0.32 per share.
| Cash & Cash Equivalents | 16.44M |
| Total Debt | 19.58M |
| Net Cash | -3.14M |
| Net Cash Per Share | -$0.32 |
| Equity (Book Value) | 45.37M |
| Book Value Per Share | 11.61 |
| Working Capital | 18.48M |
Full Balance SheetCash Flow
| Operating Cash Flow | -26.06M |
| Capital Expenditures | n/a |
| Free Cash Flow | -26.06M |
| FCF Per Share | -$2.69 |
Full Cash Flow StatementMargins
Gross margin is 5.06%, with operating and profit margins of -184.85% and -271.02%.
| Gross Margin | 5.06% |
| Operating Margin | -184.85% |
| Pretax Margin | -270.86% |
| Profit Margin | -271.02% |
| EBITDA Margin | -138.03% |
| EBIT Margin | -184.85% |
| FCF Margin | n/a |
Dividends & Yields
BNGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -183.33% |
| Shareholder Yield | -183.33% |
| Earnings Yield | -426.58% |
| FCF Yield | -149.58% |
Analyst Forecast
The average price target for BNGO is $7.67, which is 323.76% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.67 |
| Price Target Difference | 323.76% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 21.56% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 1:60.
| Last Split Date | Jan 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:60 |
Scores
BNGO has an Altman Z-Score of -14.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.02 |
| Piotroski F-Score | 3 |
